Portfolio company
iFAST
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
iFAST Diagnostics develops rapid antimicrobial susceptibility testing systems for hospital laboratories to identify effective antibiotics for treating bacterial infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
i2a
This company develops instruments, software and reagents for microbiology laboratories to automate clinical testing and identify bacterial resistance to antibiotics.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
ShanX
ShanX Medtech develops in-vitro diagnostic platforms for rapid antibiotic susceptibility testing to help clinicians treat bacterial infections in point-of-care and laboratory settings.
Astratus
Astratus develops rapid microfluidic diagnostic tests and prototype instrument readers for antimicrobial susceptibility testing in human and veterinary clinical laboratories.
